Confronting Unequal Eye Care in Pennsylvania



Status:Completed
Conditions:Ocular, Diabetes
Therapuetic Areas:Endocrinology, Ophthalmology
Healthy:No
Age Range:65 - Any
Updated:11/30/-0001
Start Date:October 2010
End Date:May 2014
Contact:David Weiss, BA
Email:dweiss@willseye.org
Phone:267-285-7659

Use our guide to learn which trials are right for you!


Diabetic retinopathy is a common eye condition among diabetic adults and can lead to severe
vision impairment and even blindness. African Americans are more likely to have vision loss
from diabetic retinopathy due to a variety of factors, including cultural barriers to care.
The investigators aim to increase the rates of eye exams in diabetic African American adults
by providing culturally relevant home-based interventions. These interventions will
increase the knowledge about diabetes and the eyes and the awareness of ocular risks due to
diabetes.

206 African American adults, over the age of 65, with diabetes will be recruited from
primary care clinics at Thomas Jefferson and Temple University. Eligible patients who
consent to participate will have baseline information taken about medical and ocular
history, understanding of diabetes and a hemoglobin A1C level obtained. The subjects will
then be randomized to one of two treatment conditions: Behavioral Activation or Supportive
Therapy, each of which will be delivered over 4 sessions. Behavioral Activation will
consist of educational materials, referral assistance for eye clinics, and addressing
patient specific barriers to care. Supportive Therapy will consist of supportive but
non-directional interaction with the patient exploring the impact of aging and diabetes on
the patient's life. The investigators hypothesize that more patients who receive Behavioral
Activation will have a dilated fundus exam (the primary outcome variable), understand the
risks of diabetic complications and feel less depression then subjects who receive
Supportive Therapy.


Inclusion Criteria:

- African-American race (self-identified)

- Age ≥ 65 years

- Type II Diabetes Mellitus (physician diagnosis) for at least 1 year

- No medical documentation of a DFE by an ophthalmologist or an optometrist within the
past 12 months

- Self-report of no DFE within the past 12 months

Exclusion Criteria:

- Cognitive Impairment (Mini-Mental Status Examination ≤ 24)

- Current clinically significant psychiatric disorder other than depression

- Current medical disorder that limits life expectancy (≤ 12 months) or need for
dialysis

- Hearing impairment that precludes research participation
We found this trial at
3
sites
1020 Walnut St
Philadelphia, Pennsylvania 19107
(215) 955-6000
Thomas Jefferson University We are dedicated to the health sciences and committed to educating professionals,...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19107
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
1801 N Broad St
Philadelphia, Pennsylvania 19122
(215) 204-7000
Temple University Temple University is many things to many people. A place to pursue life's...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials